Register entry
- Registered sites
- 3
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
positron emission tomography drug production3
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| N-Molecular, Inc. dba SOFIE | 25 Walker Way, Suite 3D, Colonie, New York (NY) 12205, United States (USA) | positron emission tomography drug production | 3008302705079932634 |
| N-Molecular, Inc. dba SOFIE | 11 Rogers Road, Suite 6, Haverhill, Massachusetts (MA) 01835, United States (USA) | positron emission tomography drug production | 3005693151079932640 |
| N-Molecular Inc. dba SOFIERegistrant: N-Molecular, Inc. dba SOFIE | 7650 First Place, Bldg B, Suite A, Oakwood Village, Ohio (OH) 44146, United States (USA) | positron emission tomography drug production | 3008685981079932600 |
Compare
Comparable companies in United States
- ProPharma Distribution, LLC.3 sites · 100 NDC
- Curium US LLC3 sites · 34 NDC
- Mayo Clinic PET Radiochemistry Facility3 sites · 0 NDC
- The University of Texas MD Anderson Cancer Center2 sites · 1 NDC
- Molecular Imaging Program At Stanford2 sites · 0 NDC
- Jubilant DraxImage Inc., dba Jubilant Radiopharma5 sites · 11 NDC
- Biomedical Research Foundation of Northwest Louisiana1 site · 4 NDC
- The Feinstein Institutes for Medical Research1 site · 4 NDC
- 3D Imaging Drug Design and Development1 site · 3 NDC
- Kreitchman PET Center1 site · 3 NDC
Enquiry
Common questions
- Is N-Molecular, Inc. dba SOFIE FDA approved?
- N-Molecular, Inc. dba SOFIE holds 3 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are N-Molecular, Inc. dba SOFIE's registered sites?
- The FDA register lists Colonie, NY; Haverhill, MA; Oakwood Village, OH. Registered operations: positron emission tomography drug production.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.